SOHM, Inc. Entering the Huge USA Generic Pharmaceutical Market
16 Marzo 2012 - 3:30PM
Marketwired
SOHM, Inc. (PINKSHEETS: SHMN) is a globally known generic
pharmaceutical manufacturer, developer and marketer having a vast
range of products, covering almost all the therapeutic segments,
has grown strength by strength with its thriving acquisitions and
strategic tie-ups.
As part of expansions, SOHM has made a strategic alliance with a
US FDA approved plant and is entering into the USA generic market.
The company has been in negotiations with one of the large
pharmaceutical distributors in the USA for supplying its generic
products into the US market.
Mr. Shailesh Shah, President & C.E.O., SOHM, Inc.,
expresses, "SOHM actively reviews pharmaceutical patents and seeks
opportunities to introduce its generic products where the patents
have expired or are invalid." He adds, "Our strong customer
relationship, quality generic products and synched supply chain
management have helped us in creating successful track records
during the past few years."
SOHM, with the announcement of its Outlook for year 2012, has
projected to generate increased revenue by 100% and profitability
in the year 2012 and beyond. SOHM will be adopting new technologies
as well as plans to invest more towards R&D and quality control
procedures. On the other hand, the market strategies are becoming
more and more broad with the intention to enter in the Generic
Market with strong corporate alliances.
It's been over 25 years since US FDA (Food & Drug
Administration) has been approving generic pharmaceutical brands.
With the help of generic versions of prescription drugs, the
consumers can actually reduce their cost, ranging from 30% to 80%,
and still get the same quality medicine.
About SOHM, Inc.
SOHM, Inc., a growing generic pharmaceutical manufacturing and
marketing company, has its global presence with a goal to gain
continuous growth. The company has its presence in versatile
healthcare segments such as Nutraceuticals, Dermatology and all
other major therapeutic segments. SOHM is headquartered in North
America along with its manufacturing units in India. SOHM's generic
pharmaceuticals are exported globally with a focus on distribution
in emerging markets in Africa, Latin America, and Southeast Asia
mainly. To know more about SOHM, Inc., please visit
www.SOHM.com
Forward-Looking Statements
This press release is containing many safe harbour statements
such as, "project", "plan", "can", etc., keeping in mind the
guidelines of the Securities Act of 1933 and the Securities
Exchange Act of 1934, as amended by the Private Securities
Litigation Reform Act of 1995. Such statements are subject to
possible uncertain risks that may vary actual results from those
intended in or expressed by the forward-looking statements. The
company undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the
statements to reflect changed assumptions, the occurrence of
unanticipated events or changes to future operating results.
For more information, please contact: SOHM, Inc. Andrew Barwicki
Email Contact 714-522-6700
Grafico Azioni SOHM (PK) (USOTC:SHMN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni SOHM (PK) (USOTC:SHMN)
Storico
Da Giu 2023 a Giu 2024